Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Marie Møller Christensen; Tina Jorsal; Lars Peter Skat Naver; Tina Vilsbøll; Filip Krag Knop

Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Translated title of the contribution: Gastric aspiration therapy is a possible alternative to treatment of obesity

Marie Møller Christensen, Tina Jorsal, Lars Peter Skat Naver, Tina Vilsbøll, Filip Krag Knop

Department of Clinical Medicine

Abstract

Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate approximately 30% of an ingested meal through a draining system connected to a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the US Food and Drug Administration, and it induces weight loss comparable to the weight loss observed after bariatric surgery, but with a lower risk of complications. Few clinical studies about the efficacy and safety of AspireAssist have been carried out and published. Thus, further intervention studies evaluating acute as well as long-term effects are warranted.

Translated title of the contribution	Gastric aspiration therapy is a possible alternative to treatment of obesity
Original language	Danish
Article number	V03170198
Journal	Ugeskrift for Laeger
Volume	179
Issue number	32
Number of pages	4
ISSN	0041-5782
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://ugeskriftet.dk/videnskab/gastrisk-aspirationsbehandling-er-et-muligt-alternativ-til-behandling-af-fedme

Cite this

@article{ae9e00b161f641ccbedeb57dc5b777d2,

title = "Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme",

abstract = "Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate approximately 30% of an ingested meal through a draining system connected to a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the US Food and Drug Administration, and it induces weight loss comparable to the weight loss observed after bariatric surgery, but with a lower risk of complications. Few clinical studies about the efficacy and safety of AspireAssist have been carried out and published. Thus, further intervention studies evaluating acute as well as long-term effects are warranted.",

author = "{M{\o}ller Christensen}, Marie and Tina Jorsal and Naver, {Lars Peter Skat} and Tina Vilsb{\o}ll and Knop, {Filip Krag}",

year = "2017",

language = "Dansk",

volume = "179",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "32",

}

TY - JOUR

T1 - Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

AU - Møller Christensen, Marie

AU - Jorsal, Tina

AU - Naver, Lars Peter Skat

AU - Vilsbøll, Tina

AU - Knop, Filip Krag

PY - 2017

Y1 - 2017

N2 - Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate approximately 30% of an ingested meal through a draining system connected to a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the US Food and Drug Administration, and it induces weight loss comparable to the weight loss observed after bariatric surgery, but with a lower risk of complications. Few clinical studies about the efficacy and safety of AspireAssist have been carried out and published. Thus, further intervention studies evaluating acute as well as long-term effects are warranted.

AB - Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate approximately 30% of an ingested meal through a draining system connected to a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the US Food and Drug Administration, and it induces weight loss comparable to the weight loss observed after bariatric surgery, but with a lower risk of complications. Few clinical studies about the efficacy and safety of AspireAssist have been carried out and published. Thus, further intervention studies evaluating acute as well as long-term effects are warranted.

M3 - Tidsskriftartikel

C2 - 28869025

SN - 0041-5782

VL - 179

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 32

M1 - V03170198

ER -

Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this